ABPI and EFPIA call for medicines prioritisation in UK/EU trade talks
Pharma industry bodies call for medicine supply to be safeguarded in upcoming talks
Read More
Tag: EFPIA
EU research-based industry unveils COVID-19 commitments
As of this morning – Wednesday April 1 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 25,150, with 1,789 deaths.
Read More
Pharma comments on Brexit withdrawal rejection
Pharmaceutical groups weigh in on the UK parliament’s rejection of the Brexit withdrawal agreement.
Read More
EMA move: “London’s loss is Amsterdam’s gain”
Amsterdam has been named as the new home of the European Medicines Agency, triggering the start of an “ambitious” relocation programme that must be completed within 16 months.
Read More
EFPIA urges co-operation to protect patients post Brexit
Nearly half (45 percent) of members of the European Federation of Pharmaceutical Industries and Associations members are expecting trade delays if the UK and Europe fail to reach a deal for Brexit.
Read More
Pharma heads call for decision on EMA relocation
Pharma chiefs in Europe are calling on heads of state to reach a prompt decision on the new location for the European Medicines Agency, which is to depart from the UK as a result of Brexit.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
